Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Madden

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The International Journal on Drug Policy|March 20, 2022
A gender lens is needed in hepatitis C elimination researchSarah Larney, Annie Madden, Alison D Marshall, et al.
Drug and Alcohol Review|March 20, 2023
Vale Jude ByrneAnnie Madden, Anna Olsen, Peter Higgs, et al.
Drug and Alcohol Review|June 20, 2024
Ageing disgracefully with Jude Byrne: A special section recognising her life and workAnna Olsen, Chris Gough, Annie Madden, et al.
Vaccine|September 14, 2010
Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesLisa Maher, Bethany White, Margaret Hellard, et al.
The International Journal on Drug Policy|June 10, 2019
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C eliminationGraham Brown, Gari-Emma Perry, Jude Byrne, et al.
Vaccine|August 19, 2014
Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness studyBethany White, Annie Madden, Maria Prins, et al.
Drug and Alcohol Review|November 2, 2012
Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugsBethany White, Annie Madden, Margaret Hellard, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
The International Journal on Drug Policy|April 28, 2026
Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugsKennedy Kipkoech Mutai, Carlo Delfin S Estadilla, Adelina Artenie, et al.
The International Journal on Drug Policy|July 1, 2017
Re-examining blood donor deferral criteria relating to injecting drug useBrendan Quinn, Clive Seed, Anthony Keller, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The International Journal on Drug Policy|March 20, 2022
A gender lens is needed in hepatitis C elimination researchSarah Larney, Annie Madden, Alison D Marshall, et al.
Drug and Alcohol Review|March 20, 2023
Vale Jude ByrneAnnie Madden, Anna Olsen, Peter Higgs, et al.
Drug and Alcohol Review|June 20, 2024
Ageing disgracefully with Jude Byrne: A special section recognising her life and workAnna Olsen, Chris Gough, Annie Madden, et al.
Vaccine|September 14, 2010
Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunitiesLisa Maher, Bethany White, Margaret Hellard, et al.
The International Journal on Drug Policy|June 10, 2019
Characterising the policy influence of peer-based drug user organisations in the context of hepatitis C eliminationGraham Brown, Gari-Emma Perry, Jude Byrne, et al.
Vaccine|August 19, 2014
Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness studyBethany White, Annie Madden, Maria Prins, et al.
Drug and Alcohol Review|November 2, 2012
Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugsBethany White, Annie Madden, Margaret Hellard, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
The International Journal on Drug Policy|April 28, 2026
Modelling the impact of cuts in US PEPFAR funding for opioid agonist therapy and needle and syringe programmes on drug-related deaths and HIV and hepatitis C transmission among people who inject drugsKennedy Kipkoech Mutai, Carlo Delfin S Estadilla, Adelina Artenie, et al.
The International Journal on Drug Policy|July 1, 2017
Re-examining blood donor deferral criteria relating to injecting drug useBrendan Quinn, Clive Seed, Anthony Keller, et al.
Pageof 4